Home / Latest Reports / Topical Corticosteroids Market

Topical Corticosteroids Market By Type Of Formulation, Potency Class, Treatment and End User - Global Industry Analysis And Forecast To 2027

Published On : January 2019 Pages : 140 Category: Petrochemicals Report Code : CM012252

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Topical Corticosteroids Market By Type Of Formulation (Creams, Ointments and Other Type Of Formulation), Potency Class (Low, Moderate, High and Ultra-High), Treatment (Eczema, Psoriasis, Insect Stings, Contact Dermatitis and Other Treatments) and End User (Pharmacies, Dermatology Clinics, Hospitals and Other End Users) - Global Industry Analysis And Forecast To 2027

Industry Outlook

Corticosteroids are hormones natural occurring produced in the body by adrenal glands. Topical corticosteroids are man-made (synthetic) medications of corticosteroids developed for treating various skin problems like dermatitis, eczema, rash, psoriasis and itching. Topical Corticosteroids possesses anti-inflammatory properties also the power of suppressing immune response. Use of Topical Corticosteroids is based on their power, type if skin problem & area of the body on which it is to be applied. Use of Topical Corticosteroids is growing due to; rising number of cases related to skin problems around the world, rising aged population, increasing number of cases of skin issues in children, etc. Therefore, the Topical Corticosteroids Market is anticipated to expand and has tremendous scope during the forecast period. The global Topical Corticosteroids Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Topical Corticosteroids Market is based on segment, by Type Of Formulation the market is segmented into Creams, Ointments and Other Type Of Formulation, by Potency Class the market is segmented into Low, Moderate, High and Ultra-High, by Treatment the market is segmented into Eczema, Psoriasis, Insect Stings, Contact Dermatitis and Other Treatments, and by End User the market is segmented into Pharmacies, Dermatology Clinics, Hospitals and Other End Users.

  • Topical Corticosteroids Market, By Type Of Formulation
  • Creams
  • Ointments
  • Other Type Of Formulation
  • Topical Corticosteroids Market, By Potency Class
  • Low
  • Fluocinolone Acetonide
  • Desonide
  • Betamethasone Valerate
  • Other Low Potency Class
  • Moderate
  • Triamcinolone Acetonide
  • Fludroxycortide
  • Desoximetasone
  • Hydrocortisone Valerate
  • Fluocinolone Acetonide
  • Other Moderate Potency Class
  • High
  • Halcinonide
  • Amcinonide
  • Fluocinonide
  • Other High Potency Class
  • Ultra-High
  • Diflorasone Diacetate
  • Clobetasol Propionate
  • Topical Corticosteroids Market, By Treatment
  • Eczema
  • Psoriasis
  • Insect Stings
  • Contact Dermatitis
  • Other Treatments
  • Topical Corticosteroids Market, By End User
  • Pharmacies
  • Dermatology Clinics
  • Hospitals
  • Other End Users

Regional Insights

On a global front, the Topical Corticosteroids Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). American region is dominating the Topical Corticosteroids Market share owing to growing demand for advanced tropical items & rising number of cases of skin disorder.

Topical Corticosteroids Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Pfizer Inc., Zylera Pharmaceuticals, Valeant Pharmaceuticals, Sandoz AG (Novartis AG), AstraZeneca plc, Actimis Pharmaceuticals, Almirall S.A, GlaxoSmithKline plc, Merck & Co. Inc. and Sanofi S.A. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Pfizer Inc.
  • Zylera Pharmaceuticals
  • Valeant Pharmaceuticals
  • Sandoz AG (Novartis AG)
  • AstraZeneca plc
  • Actimis Pharmaceuticals
  • Almirall S.A
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Sanofi S.A.

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Topical Corticosteroids Market, By Type Of Formulation, Estimates and Forecast, 2017-2027 ($Million)

o   Creams

o   Ointments

o   Other Type Of Formulation

·         Topical Corticosteroids Market, By Potency Class, Estimates and Forecast, 2017-2027 ($Million)

o   Low

§  Fluocinolone Acetonide

§  Desonide

§  Betamethasone Valerate

§  Other Low Potency Class

o   Moderate

§  Triamcinolone Acetonide

§  Fludroxycortide

§  Desoximetasone

§  Hydrocortisone Valerate

§  Fluocinolone Acetonide

§  Other Moderate Potency Class

o   High

§  Halcinonide

§  Amcinonide

§  Desoximetasone

§  Betamethasone Dipropionate

§  Fluocinonide

§  Other High Potency Class

o   Ultra-High

§  Diflorasone Diacetate

§  Clobetasol Propionate

·         Topical Corticosteroids Market, By Treatment, Estimates and Forecast, 2017-2027 ($Million)

o   Eczema

o   Psoriasis

o   Insect Stings

o   Contact Dermatitis

o   Other Treatments

·         Topical Corticosteroids Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Pharmacies

o   Dermatology Clinics

o   Hospitals

o   Other End Users

·         Topical Corticosteroids Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Topical Corticosteroids Market, By Country

o   U.S. Topical Corticosteroids Market

o   Canada Topical Corticosteroids Market

o   Mexico Topical Corticosteroids Market

o   Europe

§  Europe Topical Corticosteroids Market, By Country

o   Germany Topical Corticosteroids Market

o   UK Topical Corticosteroids Market

o   France Topical Corticosteroids Market

o   Russia Topical Corticosteroids Market

o   Italy Topical Corticosteroids Market

o   Rest of Europe Topical Corticosteroids Market

o   Asia-Pacific

§  Asia-Pacific Topical Corticosteroids Market, By Country

o   China Topical Corticosteroids Market

o   Japan Topical Corticosteroids Market

o   South Korea  Topical Corticosteroids Market

o   India Topical Corticosteroids Market

o   Southeast Asia Topical Corticosteroids Market

o   Rest of Asia-Pacific Topical Corticosteroids Market

o   South America

§  South America Topical Corticosteroids Market, By Country

o   Brazil Topical Corticosteroids Market

o   Argentina Topical Corticosteroids Market

o   Columbia Topical Corticosteroids Market

o   Rest of South America Topical Corticosteroids Market

o   Middle East and Africa

§  Middle East and Africa Topical Corticosteroids Market, By Country

o   Saudi Arabia Topical Corticosteroids Market

o   UAE Topical Corticosteroids Market

o   Egypt Topical Corticosteroids Market

o   Nigeria Topical Corticosteroids Market

o   South Africa Topical Corticosteroids Market

o   Rest of MEA Topical Corticosteroids Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Topical Corticosteroids Market, By Type Of Formulation

5.1.     Introduction

5.2.     Global Topical Corticosteroids Revenue and Market Share by Type Of Formulation (2017-2027)

5.2.1.  Global Topical Corticosteroids Revenue and Revenue Share by Type Of Formulation (2017-2027)

5.3.     Creams

5.3.1.  Global Creams Revenue and Growth Rate (2017-2027)

5.4.     Ointments

5.4.1.  Global Ointments Revenue and Growth Rate (2017-2027)

5.5.     Other Type Of Formulation

5.5.1.  Global Other Type Of Formulation Revenue and Growth Rate (2017-2027)

6.       Topical Corticosteroids Market, By Potency Class

6.1.     Introduction

6.2.     Global Topical Corticosteroids Revenue and Market Share by Potency Class (2017-2027)

6.2.1.  Global Topical Corticosteroids Revenue and Revenue Share by Potency Class (2017-2027)

6.3.     Low

6.3.1.  Global Low Revenue and Growth Rate (2017-2027)

6.3.2.  Global Low By Type (2017-2027)

6.3.3.  Fluocinolone Acetonide

6.3.3.1.  Global Fluocinolone Acetonide Revenue and Growth Rate (2017-2027)

6.3.4.  Desonide

6.3.4.1.  Global Desonide Revenue and Growth Rate (2017-2027)

6.3.5.  Betamethasone Valerate

6.3.5.1.  Global Betamethasone Valerate Revenue and Growth Rate (2017-2027)

6.3.6.  Other Low Potency Class

6.3.6.1.  Global Other Low Potency Class Revenue and Growth Rate (2017-2027)

6.4.     Moderate

6.4.1.  Global Moderate Revenue and Growth Rate (2017-2027)

6.4.2.  Global Moderate By Type (2017-2027)

6.4.3.  Triamcinolone Acetonide

6.4.3.1.  Global Triamcinolone Acetonide Revenue and Growth Rate (2017-2027)

6.4.4.  Fludroxycortide

6.4.4.1.  Global Fludroxycortide Revenue and Growth Rate (2017-2027)

6.4.5.  Desoximetasone

6.4.5.1.  Global Desoximetasone Revenue and Growth Rate (2017-2027)

6.4.6.  Hydrocortisone Valerate

6.4.6.1.  Global Hydrocortisone Valerate Revenue and Growth Rate (2017-2027)

6.4.7.  Fluocinolone Acetonide

6.4.7.1.  Global Fluocinolone Acetonide Revenue and Growth Rate (2017-2027)

6.4.8.  Other Moderate Potency Class

6.4.8.1.  Global Other Moderate Potency Class Revenue and Growth Rate (2017-2027)

6.5.     High

6.5.1.  Global High Revenue and Growth Rate (2017-2027)

6.5.2.  Global High By Type (2017-2027)

6.5.3.  Halcinonide

6.5.3.1.  Global Halcinonide Revenue and Growth Rate (2017-2027)

6.5.4.  Amcinonide

6.5.4.1.  Global Amcinonide Revenue and Growth Rate (2017-2027)

6.5.5.  Fluocinonide

6.5.5.1.  Global Fluocinonide Revenue and Growth Rate (2017-2027)

6.5.6.  Other High Potency Class

6.5.6.1.  Global Other High Potency Class Revenue and Growth Rate (2017-2027)

6.6.     Ultra-High

6.6.1.  Global Ultra-High Revenue and Growth Rate (2017-2027)

6.6.2.  Global Ultra-High By Type (2017-2027)

6.6.3.  Diflorasone Diacetate

6.6.3.1.  Global Diflorasone Diacetate Revenue and Growth Rate (2017-2027)

6.6.4.  Clobetasol Propionate

6.6.4.1.  Global Clobetasol Propionate Revenue and Growth Rate (2017-2027)

7.       Topical Corticosteroids Market, By Treatment

7.1.     Introduction

7.2.     Global Topical Corticosteroids Revenue and Market Share by Treatment (2017-2027)

7.2.1.  Global Topical Corticosteroids Revenue and Revenue Share by Treatment (2017-2027)

7.3.     Eczema

7.3.1.  Global Eczema Revenue and Growth Rate (2017-2027)

7.4.     Psoriasis

7.4.1.  Global Psoriasis Revenue and Growth Rate (2017-2027)

7.5.     Insect Stings

7.5.1.  Global Insect Stings Revenue and Growth Rate (2017-2027)

7.6.     Contact Dermatitis

7.6.1.  Global Contact Dermatitis Revenue and Growth Rate (2017-2027)

7.7.     Other Treatments

7.7.1.  Global Other Treatments Revenue and Growth Rate (2017-2027)

8.       Topical Corticosteroids Market, By End User

8.1.     Introduction

8.2.     Global Topical Corticosteroids Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Topical Corticosteroids Revenue and Revenue Share by End User (2017-2027)

8.3.     Pharmacies

8.3.1.  Global Pharmacies Revenue and Growth Rate (2017-2027)

8.4.     Dermatology Clinics

8.4.1.  Global Dermatology Clinics Revenue and Growth Rate (2017-2027)

8.5.     Hospitals

8.5.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

8.6.     Other End Users

8.6.1.  Global Other End Users Revenue and Growth Rate (2017-2027)

9.       Topical Corticosteroids Market, By Region

9.1.     Introduction

9.2.     Global Topical Corticosteroids Revenue and Market Share by Regions

9.2.1.  Global Topical Corticosteroids Revenue by Regions (2017-2027)

9.3.     North America Topical Corticosteroids by Countries

9.3.1.  North America Topical Corticosteroids Revenue and Growth Rate (2017-2027)

9.3.2.  North America Topical Corticosteroids Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Topical Corticosteroids by Countries

9.4.1.  Europe Topical Corticosteroids Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Topical Corticosteroids Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Topical Corticosteroids by Countries

9.5.1.  Asia-Pacific Topical Corticosteroids Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Topical Corticosteroids Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Topical Corticosteroids by Countries

9.6.1.  South America Topical Corticosteroids Revenue and Growth Rate (2017-2027)

9.6.2.  South America Topical Corticosteroids Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Topical Corticosteroids by Countries

9.7.1.  Middle East and Africa Topical Corticosteroids Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Topical Corticosteroids Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. Pfizer Inc.

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. Zylera Pharmaceuticals

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Valeant Pharmaceuticals

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Sandoz AG (Novartis AG)

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. AstraZeneca plc

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Actimis Pharmaceuticals

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Almirall S.A

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. GlaxoSmithKline plc

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. Merck & Co. Inc.

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

10.10.                   Sanofi S.A.

10.10.1.  Business Overview

10.10.2.   Service Portfolio

10.10.3.  Strategic Developments

10.10.4.   Revenue and Market Share

11.    Global Topical Corticosteroids Market Competition, by Manufacturer

11.1. Global Topical Corticosteroids Revenue and Market Share by Manufacturer (2017-2017)

11.2. Top 5 Topical Corticosteroids Manufacturer Market Share

11.3. Market Competition Trend

12.    Topical Corticosteroids Market Forecast (2017-2027)

12.1. Global Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Topical Corticosteroids Market Forecast by Regions (2017-2027)

12.2.1.      North America Topical Corticosteroids Market Forecast (2017-2027)

12.2.1.1. United States Topical Corticosteroids Market Forecast (2017-2027)

12.2.1.2. Canada Topical Corticosteroids Market Forecast (2017-2027)

12.2.1.3. Mexico Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.      Europe Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.1. Germany Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.2. France Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.3. UK Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.4. Russia Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.5. Italy Topical Corticosteroids Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.1. China Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.2. Japan Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.3. Korea Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.4. India Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Topical Corticosteroids Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Topical Corticosteroids Market Forecast (2017-2027)

12.2.4.      South America Topical Corticosteroids Market Forecast (2017-2027)

12.2.4.1. Brazil Topical Corticosteroids Market Forecast (2017-2027)

12.2.4.2. Argentina Topical Corticosteroids Market Forecast (2017-2027)

12.2.4.3. Columbia Topical Corticosteroids Market Forecast (2017-2027)

12.2.4.4. Rest of South America Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.3. Egypt Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.4. Nigeria Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.5. South Africa Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.6. Turkey Topical Corticosteroids Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Topical Corticosteroids Market Forecast (2017-2027)

12.3. Topical Corticosteroids Market Forecast by Type Of Formulation (2017-2027)

12.3.1.      Topical Corticosteroids Forecast by Type Of Formulation (2017-2027)

12.3.2.      Topical Corticosteroids Market Share Forecast by Type Of Formulation (2017-2027)

12.4. Topical Corticosteroids Market Forecast by Potency Class (2017-2027)

12.4.1.      Topical Corticosteroids Forecast by Potency Class (2017-2027)

12.4.2.      Topical Corticosteroids Market Share Forecast by Potency Class (2017-2027)

12.5. Topical Corticosteroids Market Forecast by Treatment (2017-2027)

12.5.1.      Topical Corticosteroids Forecast by Treatment (2017-2027)

12.5.2.      Topical Corticosteroids Market Share Forecast by Treatment (2017-2027)

12.6. Topical Corticosteroids Market Forecast by End User (2017-2027)

12.6.1.      Topical Corticosteroids Forecast by End User (2017-2027)

12.6.2.      Topical Corticosteroids Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Topical Corticosteroids Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Topical Corticosteroids Revenue and Revenue Share by Type Of Formulation (2017-2018)
Figure Global Creams Revenue and Growth Rate (2017-2018)
Figure Global Ointments Revenue and Growth Rate (2017-2018)
Figure Global Other Type Of Formulation Revenue and Growth Rate (2017-2018)
Table Global Topical Corticosteroids Revenue and Revenue Share by Potency Class (2017-2018)
Figure Global Low Revenue and Growth Rate (2017-2018)
Figure Global Fluocinolone Acetonide Revenue and Growth Rate (2017-2018)
Figure Global Desonide Revenue and Growth Rate (2017-2018)
Figure Global Betamethasone Valerate Revenue and Growth Rate (2017-2018)
Figure Global Other Low Potency Class Revenue and Growth Rate (2017-2018)
Figure Global Moderate Revenue and Growth Rate (2017-2018)
Figure Global Triamcinolone Acetonide Revenue and Growth Rate (2017-2018)
Figure Global Fludroxycortide Revenue and Growth Rate (2017-2018)
Figure Global Desoximetasone Revenue and Growth Rate (2017-2018)
Figure Global Hydrocortisone Valerate Revenue and Growth Rate (2017-2018)
Figure Global Fluocinolone Acetonide Revenue and Growth Rate (2017-2018)
Figure Global Other Moderate Potency Class Revenue and Growth Rate (2017-2018)
Figure Global High Revenue and Growth Rate (2017-2018)
Figure Global Halcinonide Revenue and Growth Rate (2017-2018)
Figure Global Amcinonide Revenue and Growth Rate (2017-2018)
Figure Global Fluocinonide Revenue and Growth Rate (2017-2018)
Figure Global Other High Potency Class Revenue and Growth Rate (2017-2018)
Figure Global Ultra-High Revenue and Growth Rate (2017-2018)
Figure Global Diflorasone Diacetate Revenue and Growth Rate (2017-2018)
Figure Global Clobetasol Propionate Revenue and Growth Rate (2017-2018)
Table Global Topical Corticosteroids Revenue and Revenue Share by Treatment (2017-2018)
Figure Global Eczema Revenue and Growth Rate (2017-2018)
Figure Global Psoriasis Revenue and Growth Rate (2017-2018)
Figure Global Insect Stings Revenue and Growth Rate (2017-2018)
Figure Global Contact Dermatitis Revenue and Growth Rate (2017-2018)
Figure Global Other Treatments Revenue and Growth Rate (2017-2018)
Table Global Topical Corticosteroids Revenue and Revenue Share by End User (2017-2018)
Figure Global Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Dermatology Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Other End Users Revenue and Growth Rate (2017-2018)
Table Global Topical Corticosteroids Revenue by Regions (2017-2018)
Figure North America Topical Corticosteroids Growth Rate (2017-2018)
Figure North America Topical Corticosteroids Revenue and Growth Rate (2017-2018)
Figure North America Topical Corticosteroids by Countries (2017-2018)
Figure North America Topical Corticosteroids Revenue (Million USD) by Countries (2017-2018)
Figure United States Topical Corticosteroids Growth Rate (2017-2018)
Figure United States Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Topical Corticosteroids Growth Rate (2017-2018)
Figure Canada Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Topical Corticosteroids Growth Rate (2017-2018)
Figure Mexico Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Topical Corticosteroids Growth Rate (2017-2018)
Figure Europe Topical Corticosteroids Revenue and Growth Rate (2017-2018)
Figure Europe Topical Corticosteroids by Countries (2017-2018)
Figure Europe Topical Corticosteroids Revenue (Million USD) by Countries (2017-2018)
Figure Germany Topical Corticosteroids Growth Rate (2017-2018)
Figure Germany Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Topical Corticosteroids Growth Rate (2017-2018)
Figure France Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Topical Corticosteroids Growth Rate (2017-2018)
Figure UK Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Topical Corticosteroids Growth Rate (2017-2018)
Figure Russia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Topical Corticosteroids Growth Rate (2017-2018)
Figure Italy Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Topical Corticosteroids Growth Rate (2017-2018)
Figure Rest of Europe Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Topical Corticosteroids Growth Rate (2017-2018)
Figure Asia-Pacific Topical Corticosteroids Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Topical Corticosteroids by Countries (2017-2018)
Figure Asia-Pacific Topical Corticosteroids Revenue (Million USD) by Countries (2017-2018)
Figure China Topical Corticosteroids Growth Rate (2017-2018)
Figure China Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Topical Corticosteroids Growth Rate (2017-2018)
Figure Japan Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Topical Corticosteroids Growth Rate (2017-2018)
Figure Korea Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Topical Corticosteroids Growth Rate (2017-2018)
Figure India Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Topical Corticosteroids Growth Rate (2017-2018)
Figure Southeast Asia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Topical Corticosteroids Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Topical Corticosteroids Growth Rate (2017-2018)
Figure South America Topical Corticosteroids Revenue and Growth Rate (2017-2018)
Figure South America Topical Corticosteroids by Countries (2017-2018)
Figure South America Topical Corticosteroids Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Topical Corticosteroids Growth Rate (2017-2018)
Figure Brazil Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Topical Corticosteroids Growth Rate (2017-2018)
Figure Argentina Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Topical Corticosteroids Growth Rate (2017-2018)
Figure Columbia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Topical Corticosteroids Growth Rate (2017-2018)
Figure Rest of South America Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Topical Corticosteroids Growth Rate (2017-2018)
Figure Middle East and Africa Topical Corticosteroids Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Topical Corticosteroids by Countries (2017-2018)
Figure Middle East and Africa Topical Corticosteroids Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Topical Corticosteroids Growth Rate (2017-2018)
Figure Saudi Arabia Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Topical Corticosteroids Growth Rate (2017-2018)
Figure United Arab Emirates Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Topical Corticosteroids Growth Rate (2017-2018)
Figure Egypt Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Topical Corticosteroids Growth Rate (2017-2018)
Figure Nigeria Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Topical Corticosteroids Growth Rate (2017-2018)
Figure South Africa Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Topical Corticosteroids Growth Rate (2017-2018)
Figure Turkey Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Topical Corticosteroids Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer Inc. Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Zylera Pharmaceuticals Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Valeant Pharmaceuticals Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sandoz AG (Novartis AG) Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AstraZeneca plc Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Actimis Pharmaceuticals Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Almirall S.A Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Inc. Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi S.A. Topical Corticosteroids Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Topical Corticosteroids Market Share by Manufacturer
Figure Global Topical Corticosteroids Revenue and Market Share by Manufacturer
Table Global Topical Corticosteroids Price by Region (2017-2017)
Figure Top 5 Topical Corticosteroids Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Topical Corticosteroids Revenue (Millions USD) and Growth Rate (2018-2025)
Table Topical Corticosteroids Market Forecast by Regions (2018-2025)
Figure North America Topical Corticosteroids Market Forecast (2018-2025)
Figure United States Topical Corticosteroids Market Forecast (2018-2025)
Figure Canada Topical Corticosteroids Market Forecast (2018-2025)
Figure Mexico Topical Corticosteroids Market Forecast (2018-2025)
Figure Europe Topical Corticosteroids Market Forecast (2018-2025)
Figure Germany Topical Corticosteroids Market Forecast (2018-2025)
Figure France Topical Corticosteroids Market Forecast (2018-2025)
Figure UK Topical Corticosteroids Market Forecast (2018-2025)
Figure Russia Topical Corticosteroids Market Forecast (2018-2025)
Figure Italy Topical Corticosteroids Market Forecast (2018-2025)
Figure Rest of Europe Topical Corticosteroids Market Forecast (2018-2025)
Figure Asia-Pacific Topical Corticosteroids Market Forecast (2018-2025)
Figure China Topical Corticosteroids Market Forecast (2018-2025)
Figure Japan Topical Corticosteroids Market Forecast (2018-2025)
Figure Korea Topical Corticosteroids Market Forecast (2018-2025)
Figure India Topical Corticosteroids Market Forecast (2018-2025)
Figure Southeast Asia Topical Corticosteroids Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Topical Corticosteroids Market Forecast (2018-2025)
Figure South America Topical Corticosteroids Market Forecast (2018-2025)
Figure Brazil Topical Corticosteroids Market Forecast (2018-2025)
Figure Argentina Topical Corticosteroids Market Forecast (2018-2025)
Figure Columbia Topical Corticosteroids Market Forecast (2018-2025)
Figure Rest of South America Topical Corticosteroids Market Forecast (2018-2025)
Figure Middle East and Africa Topical Corticosteroids Market Forecast (2018-2025)
Figure Saudi Arabia Topical Corticosteroids Market Forecast (2018-2025)
Figure United Arab Emirates Topical Corticosteroids Market Forecast (2018-2025)
Figure Egypt Topical Corticosteroids Market Forecast (2018-2025)
Figure Nigeria Topical Corticosteroids Market Forecast (2018-2025)
Figure South Africa Topical Corticosteroids Market Forecast (2018-2025)
Figure Turkey Topical Corticosteroids Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Topical Corticosteroids Market Forecast (2018-2025)
Figure Global Topical Corticosteroids Forecast by Type Of Formulation (2018-2025)
Figure Global Topical Corticosteroids Market Share Forecast by Type Of Formulation (2018-2025)
Figure Global Topical Corticosteroids Forecast by Type Of Formulation (2018-2025)
Figure Global Topical Corticosteroids Forecast by Potency Class (2018-2025)
Figure Global Topical Corticosteroids Market Share Forecast by Potency Class (2018-2025)
Figure Global Topical Corticosteroids Forecast by Potency Class (2018-2025)
Figure Global Topical Corticosteroids Forecast by Treatment (2018-2025)
Figure Global Topical Corticosteroids Market Share Forecast by Treatment (2018-2025)
Figure Global Topical Corticosteroids Forecast by Treatment (2018-2025)
Figure Global Topical Corticosteroids Forecast by End User (2018-2025)
Figure Global Topical Corticosteroids Market Share Forecast by End User (2018-2025)
Figure Global Topical Corticosteroids Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample